Gene · 6009
Papers4,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pituitary Tumorigenesis-Implications for Management. | Medicina (Kaunas) | 2023 | 37109772 | PubTator, text mining | PubMed |
| Effects of Turmeric Extract on Age-Related Skeletal Muscle Atrophy in Senescence-Accelerated Mice. | Life (Basel) | 2023 | 37109470 | PubTator, text mining | PubMed |
| Primary and Immortalized Cultures of Human Proximal Tubule Cells Possess Both Progenitor and Non-Progenitor Cells That Can Impact Experimental Results. | J Pers Med | 2023 | 37108999 | PubTator, text mining | PubMed |
| Microtubule Cytoskeletal Network Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders. | Int J Mol Sci | 2023 | 37108467 | PubTator, text mining | PubMed |
| Research Progress on Autophagy Regulation by Active Ingredients of Traditional Chinese Medicine in the Treatment of Acute Lung Injury. | J Inflamm Res | 2023 | 37092134 | PubTator, text mining | PubMed |
| Role of FLCN Phosphorylation in Insulin-Mediated mTORC1 Activation and Tumorigenesis. | Adv Sci (Weinh) | 2023 | 37083230 | PubTator, text mining | PubMed |
| Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma. | Front Med (Lausanne) | 2023 | 37081847 | PubTator, text mining | PubMed |
| The therapeutic potential of neurofibromin signaling pathways and binding partners. | Commun Biol | 2023 | 37081086 | PubTator, text mining | PubMed |
| High-Intensity interval training reduces transcriptomic age: A randomized controlled trial. | Aging Cell | 2023 | 37078430 | PubTator, text mining | PubMed |
| Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review. | Front Med (Lausanne) | 2023 | 37077668 | PubTator, text mining | PubMed |
| Case report: A gain-of-function of hamartin may lead to a distinct "inverse TSC1-hamartin" phenotype characterized by reduced cell growth. | Front Pediatr | 2023 | 37063680 | PubTator, text mining | PubMed |
| Nanomedicines: intervention in inflammatory pathways of cancer. | Inflammopharmacology | 2023 | 37060398 | PubTator, text mining | PubMed |
| Probing mutation-induced conformational transformation of the GTP/M-RAS complex through Gaussian accelerated molecular dynamics simulations. | J Enzyme Inhib Med Chem | 2023 | 37057639 | PubTator, text mining | PubMed |
| Insights into the impact of hepatitis B virus on hepatic stellate cell activation. | Cell Commun Signal | 2023 | 37041599 | PubTator, text mining | PubMed |
| Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37037849 | PubTator, text mining | PubMed |
| Editorial: Cellular senescence in physiology and pathophysiology. | Front Physiol | 2023 | 37035657 | PubTator, text mining | PubMed |
| Autophagy and its therapeutic potential in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2023 | 37020591 | PubTator, text mining | PubMed |
| Expression of the primate-specific LINC00473 RNA in mouse neurons promotes excitability and CREB-regulated transcription. | J Biol Chem | 2023 | 37019214 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Pathogenic RHEB Somatic Variant in a Child With Tuberous Sclerosis Complex Without Pathogenic Variants in TSC1 or TSC2. | Neurology | 2023 | 37015817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6009/papers?page=20